© Copyright - Newspaper WordPress Theme by TagDiv
Nebivolol
Also known as / Synonyms: Nebivolol Hydrochloride, Third-Generation Beta-Blocker
Vasodilating beta-1 selective blocker that lowers blood pressure and supports chronic heart failure management via nitric oxide release.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment of essential hypertension (alone or in combination with other antihypertensive agents).
- Adjunctive treatment of chronic stable mild-to-moderate heart failure in elderly patients (>= 70 years) with reduced or preserved ejection fraction.
- Favored over older beta-blockers due to nitric oxide (NO)-mediated vasodilatory properties and minimal erectile dysfunction liability.
Contraindications (Do Not Use If…)
- Severe bradycardia (heart rate < 60 bpm prior to initiation).
- Heart block greater than first degree (second or third-degree AV block) without a functioning pacemaker.
- Cardiogenic shock or decompensated heart failure requiring IV inotropic therapy.
- Sick sinus syndrome.
- Severe hepatic impairment (Child-Pugh > B).
- Severe peripheral arterial circulatory disorders.
Important Clinical Precautions & Warnings
- Abrupt cessation: do not abruptly discontinue beta-blocker therapy; taper over 1 to 2 weeks to avoid rebound hypertension, angina, or myocardial infarction.
- Bronchospastic disease: patients with asthma or COPD should generally avoid beta-blockers; if necessary, nebivolol's high beta-1 selectivity offers lower bronchospasm risk at low doses.
- Hypoglycemia masking: may mask adrenergic warning signs of acute hypoglycemia (tachycardia, tremors).
- Peripheral vascular disease: may precipitate or aggravate symptoms of arterial insufficiency.
- Poor CYP2D6 metabolizers: have higher plasma levels; initiate at 2.5 mg once daily.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and effectiveness have not been established in patients under 18 years. Geriatric: Start at 2.5 mg once daily in patients >= 65 years. Titrate cautiously according to clinical response and heart rate.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Headache, dizziness, fatigue, paresthesias, bradycardia, dyspnea, nausea, and peripheral edema.
Serious Side Effects — Seek Urgent Medical Care
Severe symptomatic bradycardia, AV block, acute heart failure exacerbation, bronchospasm, and cardiogenic shock.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- CYP2D6 inhibitors (fluoxetine, paroxetine, quinidine): markedly increase nebivolol levels; use with caution and lower starting dose.
- Calcium-channel blockers (verapamil, diltiazem): additive negative inotropic and chronotropic effects; heightened AV block and severe bradycardia risk.
- Digoxin: co-administration may slow AV conduction and exacerbate bradycardia.
- Clonidine: rebound hypertension risk upon clonidine withdrawal is accentuated by beta-blockers; withdraw beta-blocker several days before tapering clonidine.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesBeta-blockers can decrease placental perfusion, resulting in intrauterine growth restriction, fetal bradycardia, and hypoglycemia in newborns. Nebivolol should be used during pregnancy only if the potential benefit justifies potential fetal risks.
Lactation & Breastfeeding:
Use with caution — see notesAnimal studies show excretion in breast milk. Due to potential serious bradycardia and hypoglycemia in nursing infants, breastfeeding is not recommended.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store at 20°C to 25°C (68°F to 77°F). Protect from excessive heat and moisture.
⏱️ Missed Dose Protocol:
Take the missed dose as soon as remembered on that day. If close to the next scheduled dose, skip and resume regular timing. Do not double dose.
Overdose causes excessive bradycardia, hypotension, acute heart failure, bronchospasm, and hypoglycemia. Administer IV atropine for bradycardia, IV glucagon or dobutamine for myocardial depression.
